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Background: Idiopathic dilated cardiomyopathy is a severe cause of cardiac ventricular dilation and systolic dysfunction that shows extensive 
genetic heterogeneity. Mutations in sarcomere proteins have been well-studied in hypertrophic cardiomyopathy but the prevalence of and 
phenotypic characteristics of sarcomere protein mutations in the dilated phenotype are less understood.
Methods: We undertook mutation screening of 242 well-phenotyped subjects with dilated cardiomyopathy from 179 families (129 familial and 
50 sporadic cases) using denaturing high-performance liquid chromatography and sequence analysis. Four sarcomeric genes (MHY7, MYBPC3, 
LDB3, and TNNT2) were tested. Putative mutations were evaluated for pathogenicity by testing samples from available relatives and excluding the 
mutations from healthy controls and available polymorphism databases.
Results: 2 mutations were detected in 86 subjects tested for MHY7 (2.3%) (M982T, R1434C) and 3 mutations in 209 (1.4%) tested for MYBPC3 
(3 missense mutations: S217G, R458H, Ser956Thr) for an overall prevalence of 5/242 (4.1%). No clear mutations were identified in LDB3 or TNNT2. 
The phenotypes were severe with two mutation carriers having arrhythmias and four mutation carriers have undergone cardiac transplantation.
Conclusions: Our study, which includes the largest screen of MYBPC3 in dilated cardiomyopathy, found that mutations in MHY7 and MYBPC3 
account for approximately 2% of this phenotype. While rare, the mutations found in our study suggest that sarcomeric mutations leading to dilated 
cardiomyopathy have a severe phenotype.
